Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Frappaz

Showing results (101-110 of 189) with videos related to

Pageof 19
Sort By:
Surgical Oncology|March 31, 2012
Prognosis of malignant sacrococcygeal germ cell tumours according to their natural history and surgical managementFederica De Corti, Sabine Sarnacki, C Patte, et al.
Cancer Genetics and Cytogenetics|February 1, 1986
Persistence of t(4;11) in cytologically normal bone marrow treated ex vivo with Asta-ZM F Bertheas, D Frappaz, J Fraisse, et al.
Pediatrie|January 1, 1988
[Current results of intensive chemotherapy as salvage with bone marrow graft in highly malignant T lymphomas. Apropos of 10 cases]F Meziane, T Philip, P Biron, et al.
Pediatric Blood & Cancer|November 11, 2006
Outcome of children treated with preradiation chemotherapy for a high-grade glioma: results of a French Society of Pediatric Oncology (SFOP) Pilot StudyP Chastagner, C Kalifa, F Doz, et al.
British Journal of Haematology|February 1, 1987
Effective multiagent chemotherapy in children with advanced B-cell lymphoma: who remains the high risk patient?T Philip, R Pinkerton, P Biron, et al.
International Journal of Cancer. Supplement = Journal International Du Cancer. Supplement|February 19, 2000
Cross-cultural adaptation of a health status classification system in children with cancer. First results of the French adaptation of the Health Utilities Index Marks 2 and 3C Le Galès, N Costet, J C Gentet, et al.
Pathologie-Biologie|September 1, 1986
[Chromosome polymorphism in allogeneic bone marrow grafts. Methods and results]M F Berthéas, D Frappaz, B Mascret, et al.
British Journal of Cancer|June 1, 1995
Is neuroblastoma screening evaluation needed and feasible?J Estève, L Parker, P Roy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1993
Impact of megatherapy on survival after relapse from stage 4 neuroblastoma in patients over 1 year of age at diagnosis: a report from the European Group for Bone Marrow TransplantationR Ladenstein, C Lasset, O Hartmann, et al.
Pediatric Hematology and Oncology|July 1, 1994
Isolated intraspinal relapse of neuroblastoma after autologous bone marrow transplantationD Frappaz, E Bouffet, P Thiesse, et al.
Pageof 19

Showing results (101-110 of 189) with videos related to

Sort By:
Pageof 19
Surgical Oncology|March 31, 2012
Prognosis of malignant sacrococcygeal germ cell tumours according to their natural history and surgical managementFederica De Corti, Sabine Sarnacki, C Patte, et al.
Cancer Genetics and Cytogenetics|February 1, 1986
Persistence of t(4;11) in cytologically normal bone marrow treated ex vivo with Asta-ZM F Bertheas, D Frappaz, J Fraisse, et al.
Pediatrie|January 1, 1988
[Current results of intensive chemotherapy as salvage with bone marrow graft in highly malignant T lymphomas. Apropos of 10 cases]F Meziane, T Philip, P Biron, et al.
Pediatric Blood & Cancer|November 11, 2006
Outcome of children treated with preradiation chemotherapy for a high-grade glioma: results of a French Society of Pediatric Oncology (SFOP) Pilot StudyP Chastagner, C Kalifa, F Doz, et al.
British Journal of Haematology|February 1, 1987
Effective multiagent chemotherapy in children with advanced B-cell lymphoma: who remains the high risk patient?T Philip, R Pinkerton, P Biron, et al.
International Journal of Cancer. Supplement = Journal International Du Cancer. Supplement|February 19, 2000
Cross-cultural adaptation of a health status classification system in children with cancer. First results of the French adaptation of the Health Utilities Index Marks 2 and 3C Le Galès, N Costet, J C Gentet, et al.
Pathologie-Biologie|September 1, 1986
[Chromosome polymorphism in allogeneic bone marrow grafts. Methods and results]M F Berthéas, D Frappaz, B Mascret, et al.
British Journal of Cancer|June 1, 1995
Is neuroblastoma screening evaluation needed and feasible?J Estève, L Parker, P Roy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1993
Impact of megatherapy on survival after relapse from stage 4 neuroblastoma in patients over 1 year of age at diagnosis: a report from the European Group for Bone Marrow TransplantationR Ladenstein, C Lasset, O Hartmann, et al.
Pediatric Hematology and Oncology|July 1, 1994
Isolated intraspinal relapse of neuroblastoma after autologous bone marrow transplantationD Frappaz, E Bouffet, P Thiesse, et al.
Pageof 19